Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.

Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis. Biomark Med. 2020 May 19;: Authors: Ielapi N, Licastro N, Provenzano M, Andreucci M, Franciscis S, Serra R PMID: 32426991 [PubMed - as supplied by publisher]
Source: Future Medicine: Biomarkers in Medicine - Category: Internal Medicine Tags: Biomark Med Source Type: research